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INTRODUCTION
Rubinste in-Taybi  syndrome (RTS) is  a  rare 
developmental disorder characterized by craniofacial 
dysmorphisms, broad thumbs and toes as well as mental 
and statural deficiencies.1 RTS has a prevalence of 1 in 
330,000 births2 and usually occurs sporadically, although 
it can be inherited as an autosomal dominant disorder.2,4 
The diagnosis is based on characteristic features.3 The main 
clinical symptoms are failure to thrive, cardiac defects and 
recurrent respiratory infections.4 Other variable findings 
are colobomas, cataracts, renal anormalities3,4 and oro-
dental anomalies.5 RTS patients also have an increased 
risk of developing neoplasias.6,7 Several tumors have 
been reported in RTS patients, including meningiomas, 
rhabdomyosarcomas, neuroblastomas, oligodendromas, 
seminomas, choristomas and leukemias.6,7 
CREBBP and EP300 are the only genes associated with 
RTS.8,11 Microdeletions at band 16p13.3 occur in 10%–25% 
of RTS patients.9 Sequence analyses have detected CREBBP 
mutations in another 56% of affected individuals. Schorry et 
al. (2008)8 evaluated genotype-phenotype correlations in 93 
RTS patients and performed complete sequencing of all 31 
coding regions of the CREBBP gene. The authors concluded 
that there were no statistically significant differences in 
the classic dysmorphic findings of RTS patients (e.g., 
typical facial aspects and broad thumbs and toes) with and 
without CREBBP mutations. Mutations in EP300 have been 
identified in 3% of RTS patients.7,9 
RTS typically occurs as a de novo mutation in a family.2 
Most individuals represent simplex cases (i.e., the only 
affected member in a family); in most instances, the parents 
of an individual with RTS are not affected.2,4 In this case, 
the empiric recurrence risk for siblings is approximately 
0.1%. Although individuals with RTS rarely reproduce, the 
theoretical risk for the offspring is 50%.2 Prenatal testing 
for at-risk pregnancies is possible if the disease-causing 
CREBBP mutation or deletion in the family is known.7 
CASE DESCRIPTION
The propositus, a 23-year-old Brazilian female patient, 
is the third child of healthy, non-consanguineous parents. 
The infant was born pre-term by Cesarean section. The birth 
weight was 1,900 g, the length was 47 cm, the occipitofrontal 
circumference (OFC) was 36 cm, and the body mass index 
was 31.35 (mild obesity). Developmental milestones were 
delayed: she sat without support at the age of 1, walked at 2.5 
years and acquired control of the bowels at age 4. She spoke 
only a few meaningful words at the age of eighteen. The 
clinical history of the infancy and childhood was noteworthy, 
with feeding problems and recurrent respiratory infections 
Table 1 - Reciprocal translocations in RTS patients 
Karyotype References
46, XX, t(2; 16) (p13.3; p13.3) Imaizumi, Kuroki (1991)15
46, XY, t(7; 16) (q34; p13.3) Tommerup et al. (1992) 16
46, XY, t(2; 16) (q36.3; p13.3) Petrij et al. (1995)17; Giles et al. 
(1997) 19; Petrij et al. (2000) 20
46, XY, t(1; 16) (p34.1; p13.2) Wallerstein et al. (1997)21
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Chromosome preparations were obtained from peripheral 
blood lymphocytes from the propositus and her parents. 
Karyotyping with GTG banding was performed at the 
450–550 band level using standard methods9 by the Fleury 
Laboratory. The patient’s karyotype showed a balanced 
reciprocal translocation between chromosomes 2 and 16 
without visible deletion; the full karyotype is 46, XX, t(2;16)
(q36.3; p13.3) (Figure 3). The parent’s karyotypes were 
normal, so this translocation was de novo. The recurrence 
risk for the parents is very low (approximately 0.1%). 
DISCUSSION
Chromosomal rearrangements involving band 16p13.3 
form the minority (0.6%) of CREBBP mutations.18 
There have been seven reported cases of chromosomal 
rearrangements in RTS patients, and four of these were 
translocations.14-18 
The 4-year-old RTS boy described by Petrij et al. 
(1995)17 presented with the same translocation (2; 16) with 
the same breakpoints as our patient. The common clinical 
findings of this boy and our patient were feeding problems, 
short stature and recurrent respiratory infections. To the best 
of our knowledge, our RTS patient is the third reported case 
with a de novo reciprocal t (2;16) (q36.3; p13.3). 
We found no other studies describing RTS patients with 
dysgranulopoietic neutrophils. As RTS patients have an 
increased risk of hematological malignancies,6 appropriate 
laboratory testing and hematological follow-up are 
warranted. 
Figure 3 - GTG banding karyotype
Figure 2 - Broad and radially deviated thumbs
Figure 1 - A patient with the facial dysmorphisms typical of RTS
(sinusitis, otitis medias, tonsillitis and pneumonias) from 
two months of age until the age of five. Splenomegaly was 
observed at 21 years of age, and a detailed immunological 
analysis of this patient was performed by Torres (2008)13. 
Persistent mild to moderate leukocytosis (13,000 to 26,000/
mm3) was observed despite the absence of clinical signs of 
infection. Forty to fifty percent of blood neutrophils presented 
with scarce or absent granules. A myelogram also showed 
dysgranulopoietic granulocytes. 
A physical examination at 23 years of age showed 
a weight of 61 kg (75<p<97.5), a height of 139.5 cm 
(p<2.5) and an OFC of 49.5 cm (p<2.5). Pertinent physical 
characteristics were highly arched eyebrows, downward-
slanted palpebral fissures, a beaked nose, nasal septum below 
alae, a highly arched palate and posteriorly angled ears 
(Figure 1). She also had broad, radially deviated thumbs and 
broad halluces (Figure 2). 
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